Similarly, osteoblasts from the patient pair with a G589S substitution had significantly reduced levels of SP7, RUNX2, and COL1A1 expression compared to the control, except for significantly increased RUNX2 expression on Day 14 in osteoblasts from the type III OI patient. The gene discussed is SP7; the disease is osteogenesis imperfecta type 3.